AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.43
+0.81 (5.95%)
At close: Mar 9, 2026, 4:00 PM EDT
14.15
-0.28 (-1.94%)
After-hours: Mar 9, 2026, 7:56 PM EDT

AgomAb Therapeutics NV Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2019 FY 2018 2017
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '19 Dec '18 2017
Net Income
-56.88-46.27-11.39-8.14--
Upgrade
Depreciation & Amortization
0.390.310.10.02--
Upgrade
Stock-Based Compensation
4.431.072.162.21--
Upgrade
Other Operating Activities
3.64-0.66-19.58-14.47--
Upgrade
Change in Accounts Payable
-1.79-0.233.692.95--
Upgrade
Change in Unearned Revenue
0.77-0.4-0.581.45--
Upgrade
Change in Other Net Operating Assets
-1.57-0.661.01-2.99--
Upgrade
Operating Cash Flow
-51.01-46.83-24.59-18.97--
Upgrade
Capital Expenditures
-0.36-0.68----
Upgrade
Cash Acquisitions
-3---4.59--
Upgrade
Investment in Securities
--40-40--
Upgrade
Investing Cash Flow
-3.36-0.6840-44.59--
Upgrade
Long-Term Debt Issued
---0.14--
Upgrade
Long-Term Debt Repaid
--0.16-0.1-0.72--
Upgrade
Net Debt Issued (Repaid)
-0.37-0.16-0.1-0.58--
Upgrade
Issuance of Common Stock
82.0697.0679.8738.39--
Upgrade
Other Financing Activities
-0.13-0.13-0.45-0.17--
Upgrade
Financing Cash Flow
81.5696.7679.3237.63--
Upgrade
Foreign Exchange Rate Adjustments
-0.2-0.2----
Upgrade
Miscellaneous Cash Flow Adjustments
00----
Upgrade
Net Cash Flow
26.9949.0694.73-25.92--
Upgrade
Free Cash Flow
-51.37-47.5-24.59-18.97--
Upgrade
Free Cash Flow Per Share
-2054.80-1900.12-983.68-758.68--
Upgrade
Cash Interest Paid
0.010.010.020.04--
Upgrade
Cash Income Tax Paid
0000--
Upgrade
Levered Free Cash Flow
--16.51-49.9---
Upgrade
Unlevered Free Cash Flow
--16.47-49.88---
Upgrade
Change in Working Capital
-2.59-1.284.121.41--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.